Literature DB >> 24837854

Epidemiological features of intestinal infection with Entamoeba histolytica in Taiwan, 2002-2010.

Pak-On Leung1, Kou-Huang Chen2, Kwo-Liang Chen2, Yu-Ting Tsai3, Shyun-Yeu Liu4, Kow-Tong Chen5.   

Abstract

Amebiasis remains an important public health problem worldwide, and immigration and an increase in international travel have affected the incident cases of the disease. The purpose of this study was to assess the prevalence of Entamoeba histolytica in Taiwan between 2002 and 2010. We analyzed data from surveillance programs run by the Centers for Disease Control, Taiwan (Taiwan CDC), and only laboratory-confirmed cases were analyzed. In total, 1796 cases with E. histolytica infections were included in our analysis. Among them, 788 (44%) of the cases were imported, and 1008 (56%) were locally acquired. The average annual incidence rate of E. histolytica infections was 0.49 and 9.26 per 100,000 for local patients and immigrants/foreign workers from endemic countries, respectively. The annual incidence of E. histolytica infections among immigrants/foreign workers was significantly higher than among Taiwanese who had not traveled abroad (P < 0.0001). Travelers to E. histolytica-endemic areas (e.g., Southeast countries) had a higher risk acquiring an E. histolytica infection. This study emphasized that E. histolytica infection is an important intestinal infectious disease in Taiwan. The risk of infection with E. histolytica for travelers was higher for those with destinations in South and Southeast Asia. To control E. histolytica infections in Taiwan, a sensitive surveillance system needs to be established, and the amebiasis-screening program for immigrants/foreign workers from endemic countries should be enforced.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amebiasis; Immigrant; Imported case; Taiwan; Travel medicine

Mesh:

Year:  2014        PMID: 24837854     DOI: 10.1016/j.tmaid.2014.04.010

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  7 in total

1.  The Epidemiology of Entamoeba histolytica Infection and Its Associated Risk Factors among Domestic and Imported Patients in Taiwan during the 2011-2020 Period.

Authors:  Fu-Huang Lin; Bao-Chung Chen; Yu-Ching Chou; Wu-Chien Chien; Chi-Hsiang Chung; Chi-Jeng Hsieh; Chia-Peng Yu
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

2.  Epidemiology of Domestically Acquired Amebiasis in Japan, 2000-2013.

Authors:  Masahiro Ishikane; Yuzo Arima; Atsuhiro Kanayama; Takuri Takahashi; Takuya Yamagishi; Yuichiro Yahata; Tamano Matsui; Tomimasa Sunagawa; Tomoyoshi Nozaki; Kazunori Oishi
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

3.  Multiple simultaneous infections in a patient with well-controlled HIV: when Occam's razor fails.

Authors:  Miranda Sherley; Sarah Jane Martin
Journal:  BMJ Case Rep       Date:  2017-12-01

4.  Symptomatic and Asymptomatic Protist Infections in Hospital Inpatients in Southwestern China.

Authors:  Shun-Xian Zhang; David Carmena; Cristina Ballesteros; Chun-Li Yang; Jia-Xu Chen; Yan-Hong Chu; Ying-Fang Yu; Xiu-Ping Wu; Li-Guang Tian; Emmanuel Serrano
Journal:  Pathogens       Date:  2021-05-31

5.  The first case of huge amebic intra-abdominal tumor with asymptomatic amebic colitis.

Authors:  Shigeo Higami; Eiji Nomura; Masashi Yamazaki; Seiji Morita; Wataru Noguchi; Shuji Uda; Hitoshi Hara; Soichiro Yamamoto; Sayuri Hasegawa; Kosuke Tobita; Takuma Tajiri; Masaya Mukai; Sadaki Inokuchi; Hiroyasu Makuuchi
Journal:  Surg Case Rep       Date:  2015-06-16

6.  A decade of intestinal protozoan epidemiology among settled immigrants in Qatar.

Authors:  Marawan A Abu-Madi; Jerzy M Behnke; Sonia Boughattas; Asma Al-Thani; Sanjay H Doiphode
Journal:  BMC Infect Dis       Date:  2016-08-05       Impact factor: 3.090

7.  Urban transportation energy and carbon dioxide emission reduction strategies.

Authors:  Yung-Hsiang Cheng; Yu-Hern Chang; I J Lu
Journal:  Appl Energy       Date:  2015-03-09       Impact factor: 9.746

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.